Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Digestive Care
Digestive Care
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Pertzye
Pancrelipase
2012-05-17
—
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pancrelipase
short bowel syndrome
,
exocrine pancreatic insufficiency
,
chronic pancreatitis
,
cystic fibrosis
,
pancreatic neoplasms
Aspartame
mucopolysaccharidosis iv
,
mucopolysaccharidoses
,
phenylketonurias
,
hypersensitivity
,
achondroplasia
Nadide
hiv infections
,
acquired immunodeficiency syndrome
,
toxoplasmosis
,
cerebral toxoplasmosis
,
encephalitis
,
stomach neoplasms
,
esophageal neoplasms
,
diabetic neuropathies
,
covid-19
,
pain
,
peripheral nervous system diseases
,
sickle cell anemia
,
hemolysis
,
juvenile arthritis
,
crohn disease
,
chronic disease
,
failure to thrive
,
dwarfism
,
acromegaly
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use